Cancer

Bowel cancer survival has more than doubled in the last 40 years.

Clearly, not every prostate cancer patient will benefit from novel endocrine treatments, Gary Culliton reports in his latest Clinical Update.

Researchers at Trinity College Dublin and Mount Sinai in New York have published new research, which for the first time provides strong evidence on the economic benefits of early palliative care intervention for people with an advanced cancer diagnosis.

Men with a high fitness level in mid-life appear to be at lower risk for lung and colorectal cancer, but not prostate cancer, and that higher fitness level also may put them at lower risk of death if they are diagnosed with cancer when they’re older, according to a study published online by JAMA Oncology.

Breast cancer survival has improved as a result of screening, symptomatic detection and better treatment options, Gary Culliton reports in his latest Clinical Update.

In patients with relapsed multiple myeloma, the addition of carfilzomib to lenalidomide and dexamethasone resulted in improved survival and had a favourable risk-benefit profile, new research in the New England Journal of Medicine has found.

Higher proportions of women eligible for breast conservation surgery (BCS) are undergoing mastectomy, breast reconstruction and bilateral mastectomy, with large increases seen in women with lymph node-negative and in situ disease, according to a report published online by JAMA Surgery.

The cure rates for early-stage colon and rectal cancers can be over 90 per cent.

Within the next 10 to 15 years, three-quarters of patients with colorectal cancer can be expected to survive five years or longer – a huge jump in a relatively short period, Gary Culliton reports in his latest Clinical Update.

Patients have a range of options available to them before and following chemotherapy, a meeting of European experts has heard.